3-Amino-3-phenylpropionic acidCAS# 614-19-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 614-19-7 | SDF | Download SDF |
| PubChem ID | 69189 | Appearance | Powder |
| Formula | C9H11NO2 | M.Wt | 165 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 3-amino-3-phenylpropanoic acid | ||
| SMILES | C1=CC=C(C=C1)C(CC(=O)O)N | ||
| Standard InChIKey | UJOYFRCOTPUKAK-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C9H11NO2/c10-8(6-9(11)12)7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
3-Amino-3-phenylpropionic acid Dilution Calculator
3-Amino-3-phenylpropionic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 6.0606 mL | 30.303 mL | 60.6061 mL | 121.2121 mL | 151.5152 mL |
| 5 mM | 1.2121 mL | 6.0606 mL | 12.1212 mL | 24.2424 mL | 30.303 mL |
| 10 mM | 0.6061 mL | 3.0303 mL | 6.0606 mL | 12.1212 mL | 15.1515 mL |
| 50 mM | 0.1212 mL | 0.6061 mL | 1.2121 mL | 2.4242 mL | 3.0303 mL |
| 100 mM | 0.0606 mL | 0.303 mL | 0.6061 mL | 1.2121 mL | 1.5152 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Naginata ketone
Catalog No.:BCN7801
CAS No.:6138-88-1
- Trigonelline hydrochloride
Catalog No.:BCN1050
CAS No.:6138-41-6
- Rifapentine
Catalog No.:BCC4937
CAS No.:61379-65-5
- Griffonilide
Catalog No.:BCN1271
CAS No.:61371-55-9
- erythro-Guaiacylglycerol-beta-O-4'-dehydrodisinapyl ether
Catalog No.:BCN7024
CAS No.:613684-55-2
- TNP-ATP triethylammonium salt
Catalog No.:BCC7373
CAS No.:61368-63-6
- VU 0364770
Catalog No.:BCC4597
CAS No.:61350-00-3
- Boc-D-Glu-OH
Catalog No.:BCC2606
CAS No.:61348-28-6
- Boc-D-Gln-OH
Catalog No.:BCC2607
CAS No.:61348-28-5
- Amoxicillin trihydrate
Catalog No.:BCC5168
CAS No.:61336-70-7
- Neoschaftoside
Catalog No.:BCN3053
CAS No.:61328-41-4
- Sulconazole Nitrate
Catalog No.:BCC4853
CAS No.:61318-91-0
- Procainamide HCl
Catalog No.:BCC5492
CAS No.:614-39-1
- 2-Hydroxycinnamic acid
Catalog No.:BCN5039
CAS No.:614-60-8
- 2,4-Dihydroxyphenylacetic acid
Catalog No.:BCN4139
CAS No.:614-82-4
- Rolipram
Catalog No.:BCC2282
CAS No.:61413-54-5
- Carmofur
Catalog No.:BCC1214
CAS No.:61422-45-5
- 2-Amino-3-Formylchromone
Catalog No.:BCC8526
CAS No.:61424-76-8
- Z-D-Ala-ol
Catalog No.:BCC2589
CAS No.:61425-27-2
- Bisabola-3,10-dien-2-one
Catalog No.:BCN7510
CAS No.:61432-71-1
- CIS-Resveratrol
Catalog No.:BCC8150
CAS No.:61434-67-1
- Lup-20(29)-ene-2alpha,3beta-diol
Catalog No.:BCN4612
CAS No.:61448-03-1
- alpha-Mangostin
Catalog No.:BCN4138
CAS No.:6147-11-1
- Quercetin Dihydrate
Catalog No.:BCN2967
CAS No.:6151-25-3
Production of (R)-3-amino-3-phenylpropionic acid and (S)-3-amino-3-phenylpropionic acid from (R,S)-N-acetyl-3-amino-3-phenylpropionic acid using microorganisms having enantiomer-specific amidohydrolyzing activity.[Pubmed:16428826]
Biosci Biotechnol Biochem. 2006 Jan;70(1):99-106.
(R)-3-Amino-3-phenylpropionic acid ((R)-beta-Phe) and (S)-3-Amino-3-phenylpropionic acid ((S)-beta-Phe) are key compounds on account of their use as intermediates in synthesizing pharmaceuticals. Enantiomerically pure non-natural amino acids are generally prepared by enzymatic resolution of the racemic N-acetyl form, but despite the intense efforts this method could not be used for preparing enantiomerically pure beta-Phe, because the effective enzyme had not been found. Therefore, screening for microorganisms capable of amidohydrolyzing (R,S)-N-acetyl-3-Amino-3-phenylpropionic acid ((R,S)-N-Ac-beta-Phe) in an enantiomer-specific manner was performed. A microorganism having (R)-enantiomer-specific amidohydrolyzing activity and another having both (R)-enantiomer- and (S)-enantiomer-specific amidohydrolyzing activities were obtained from soil samples. Using 16S rDNA analysis, the former organism was identified as Variovorax sp., and the latter as Burkholderia sp. Using these organisms, enantiomerically pure (R)-beta-Phe (>99.5% ee) and (S)-beta-Phe (>99.5% ee) with a high molar conversion yield (67%-96%) were obtained from the racemic substrate.
Gastric acid inhibitory action of a GABA-related compound, 3-amino-3-phenylpropionic acid, in the rat.[Pubmed:1973101]
Eur J Pharmacol. 1990 Apr 10;179(1-2):17-23.
The acid inhibitory properties of 3-Amino-3-phenylpropionic acid, a structural GABA analogue, were studied in the perfused rat stomach preparation. 3-Amino-3-phenylpropionic acid, 10 and 30 mg/kg i.v., dose dependently suppressed the gastric acid secretion induced by baclofen (2 mg/kg s.c.). This secretagogue action had been shown to be unaffected by either GABAA or GABAB receptor antagonists. The i.v. administration of 3-Amino-3-phenylpropionic acid (3 and 10 mg/kg) was also effective to abolish the acid stimulatory effects of muscimol (1 mg/kg i.v.) and 2-deoxy-D-glucose (200 mg/kg i.v.). 3-Amino-3-phenylpropionic acid, even at the high dose (30 mg/kg i.v.) had no influence on the acid output in response to histamine and bethanechol. Furthermore, 3-Amino-3-phenylpropionic acid had no significant effect on the acid secretion induced by electrical vagal stimulation. These results indicate that the antisecretory effect of 3-Amino-3-phenylpropionic acid is different from those of antimuscarinics, H2-receptor antagonists and vagal blockade. Together, the results suggest that 3-Amino-3-phenylpropionic acid might act in the brain to inhibit central regulation mechanisms of gastric acid secretion, probably through GABA mechanisms.
